.view-toggle-wrapper { display: none; } #content-overview { display: block !important; } #content-technical { display: block !important; margin-top: 50px; border-top: 2px solid #ccc; padding-top: 30px; }

Use the toggle to switch between the simple Overview and the Technical Data content.

Vitamin E: Benefits, Uses, Forms, and Safety

Overview

Plain-English information for everyday use

1. What Is Vitamin E?

Key Takeaway

Vitamin E is an essential, fat-soluble antioxidant — a family of eight compounds (alpha-tocopherol is the main one) that helps protect your cell membranes.

Vitamin E is an essential, fat-soluble nutrient. Your body needs it but can't make it on its own, so it has to come from food (and, for some people, supplements). NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗

“Vitamin E” isn't a single substance. It's a family of eight related compounds — four tocopherols and four tocotrienols, each with a Greek-letter name (alpha, beta, gamma, delta). The form your body holds onto best is alpha-tocopherol. Traber. Basic Clin Pharmacol Toxicol. 2026. Open Source ↗

Its best-known job is acting as an antioxidant: it protects the fats in your cell membranes from unstable molecules called free radicals, which supports your body's natural antioxidant defenses. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗

Because it's fat-soluble, vitamin E is absorbed with the fat in your meals and stored in body fat and the liver. On labels you'll see a natural form (d-alpha, or RRR) and a synthetic form (dl-alpha); the natural form is about twice as potent per milligram. The Daily Value is 15 mg. Traber. Basic Clin Pharmacol Toxicol. 2026. Open Source ↗

2. Signs You May Be Running Low

Key Takeaway

Running low is uncommon in healthy people; it mainly affects those who can't absorb dietary fat well. Signs can include muscle and nerve changes — but only a blood test confirms it.

In healthy people who eat a normal diet, running low on vitamin E is uncommon — it's found in many everyday foods and your body keeps a store of it. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗

A shortfall is much more likely in people whose bodies have trouble absorbing dietary fat (for example, certain digestive or inherited conditions), and in babies born very prematurely. Schuelke. GeneReviews (NCBI Bookshelf NBK1241). 2023. Open Source ↗

When vitamin E does run low over a long time, some people may notice muscle weakness, trouble with balance and coordination, numbness or a “pins-and-needles” feeling in the hands and feet, or changes in vision — because nerve and muscle tissue are especially sensitive to oxidative damage. Schuelke. GeneReviews (NCBI Bookshelf NBK1241). 2023. Open Source ↗

These signs are not specific to vitamin E — feeling weak or off-balance can have many causes, and no single symptom points to any single nutrient on its own. The surest step is to speak with your healthcare provider, usually with a simple blood test, who can tell whether vitamin E is actually low. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗

3. Who Should Be Careful or Avoid

Key Takeaway

Most people get vitamin E safely from food. High-dose supplements need caution mainly because vitamin E can thin the blood — most important for people on blood thinners or facing surgery.

Most people get vitamin E safely from food and ordinary supplements. The cautions below apply mainly to high-dose supplements, and several come down to one thing: at high doses vitamin E can thin the blood. Owen. StatPearls (NCBI Bookshelf NBK564373). 2023. Open Source ↗

People taking blood thinners or anti-clotting medicines (such as warfarin, aspirin, or similar) — high-dose vitamin E can add to their effect and raise bleeding risk. This is the most important interaction; talk with your provider first. Booth. American Journal of Clinical Nutrition. 2004. Open Source ↗
Anyone scheduled for surgery — high-dose vitamin E is usually stopped about two weeks beforehand. Owen. StatPearls (NCBI Bookshelf NBK564373). 2023. Open Source ↗
People undergoing chemotherapy or radiation — there's genuine scientific debate about whether high-dose antioxidants help or interfere; don't add them without your oncology team's guidance. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗
People with an inherited eye condition called retinitis pigmentosa — high-dose vitamin E may be inadvisable; ordinary dietary amounts are fine. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗
Premature infants should never be given high-dose vitamin E by IV. Owen. StatPearls (NCBI Bookshelf NBK564373). 2023. Open Source ↗
During pregnancy or breastfeeding — food and Daily-Value amounts are fine, but high-dose supplements aren't recommended. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗

4. How to Get the Best Results

Key Takeaway

Take vitamin E with a meal that has some fat, choose the natural form, and don't mega-dose. It works with vitamins C and selenium, and needs no tapering.

Take it with a meal that has some fat. Vitamin E is fat-soluble and absorbs far better with food. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗
Know your form. The natural form (d-alpha) is more potent per milligram than synthetic (dl-alpha); “mixed tocopherols” also include gamma-tocopherol. Traber. Basic Clin Pharmacol Toxicol. 2026. Open Source ↗
It has partners. Vitamin E works with vitamin C (which helps “recharge” it) and the mineral selenium. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗
More is not better. Very high doses can work against you (see Sections 3 and 5), and can interfere with vitamin K. Booth. American Journal of Clinical Nutrition. 2004. Open Source ↗
Be realistic about timing. Blood levels reach a steady state after a few days, but most people won't “feel” a change — vitamin E is preventive nutrition, not a fast-acting remedy. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗
No need to taper. There's no withdrawal or rebound — you can simply stop (unless you're using it for a diagnosed deficiency, in which case follow your provider). NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗

5. Side Effects to Know About

Key Takeaway

At normal amounts vitamin E is well tolerated. High doses can cause stomach upset and, more seriously, increased bleeding; some studies link high doses to higher overall risk.

At normal dietary and Daily-Value amounts, vitamin E is well tolerated. Side effects are mostly a concern with high-dose supplements. Here's the honest range, from most to least common. Owen. StatPearls (NCBI Bookshelf NBK564373). 2023. Open Source ↗

More common (at high doses): stomach upset, nausea, diarrhea, headache, and tiredness. Owen. StatPearls (NCBI Bookshelf NBK564373). 2023. Open Source ↗
Less common but more serious: increased bleeding and easy bruising, because vitamin E can thin the blood at high doses. Booth. American Journal of Clinical Nutrition. 2004. Open Source ↗
Rare but serious: in some large studies, high doses were linked to a higher risk of the bleeding type of cerebrovascular event Schürks. BMJ. 2010. Open Source ↗; and several analyses linked high doses (around 400 IU per day and above) to a small increase in overall risk of death. Miller. Annals of Internal Medicine. 2005. Open Source ↗

6. What Research Suggests

Key Takeaway

The honest picture is mixed: vitamin E supplements have generally not prevented major chronic conditions in healthy people, with specific exceptions — and high doses carry real risks.

Here's the big picture first: in large, high-quality studies of healthy people, vitamin E supplements have generally not shown the broad benefits researchers once hoped for when testing them against major chronic conditions. The evidence is mixed — more encouraging for a few narrow uses, disappointing or even concerning for others. Yusuf. New England Journal of Medicine. 2000. Open Source ↗Lee. JAMA. 2005. Open Source ↗Heart Protection Study Collaborative Group. The Lancet. 2002. Open Source ↗

Where some research has been supportive (specific situations):

Aging eye health. A study of a particular antioxidant-plus-zinc combination (which included vitamin E) supported slower progression of an age-related eye condition. Vitamin E on its own did not show this. Age-Related Eye Disease Study Research Group. Archives of Ophthalmology. 2001. Open Source ↗
Liver health. In adults with a fatty-liver condition not caused by alcohol, a high daily dose improved liver-tissue measures in one major trial — that was a supervised medical study of a diagnosed condition, not a general recommendation and not something to try on your own. Sanyal. New England Journal of Medicine. 2010. Open Source ↗
A specific genetic subgroup. People with a particular inherited blood-protein type appeared to benefit in heart-related measures in some studies (see Section 11) — promising research, not established guidance. Milman. Arterioscler Thromb Vasc Biol. 2008. Open Source ↗

Where the evidence was null (no benefit found) — and these count just as much:

Heart health in the general population. Large trials — including a major high-risk study and a long-running women's health study — found vitamin E did not lower the rate of heart attacks or cardiovascular death. Yusuf. New England Journal of Medicine. 2000. Open Source ↗Lee. JAMA. 2005. Open Source ↗
A large combined-vitamin study of more than 20,000 people likewise found no benefit. Heart Protection Study Collaborative Group. The Lancet. 2002. Open Source ↗

Where the evidence was actually unfavorable — kept here on purpose:

A large prostate-health trial found more of a prostate condition among men taking vitamin E, not less. Klein. JAMA. 2011. Open Source ↗
Pooled analyses linked high doses to a small rise in overall death risk Miller. Annals of Internal Medicine. 2005. Open Source ↗ and to the bleeding type of cerebrovascular event. Schürks. BMJ. 2010. Open Source ↗

Putting it together: vitamin E's benefits appear specific and limited rather than broad, and high doses carry real risks. Researchers today are focused on figuring out who actually benefits.

7. Top Food Sources

Key Takeaway

The richest sources are plant oils, nuts, and seeds — wheat germ oil, sunflower seeds, and almonds lead. Most people can reach the 15 mg Daily Value through food.

The richest sources of vitamin E are plant oils, nuts, and seeds. Most people can reach the 15 mg Daily Value through food alone. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗

Wheat germ oil — about 20 mg per tablespoon
Sunflower seeds — about 7 mg per ounce
Almonds — about 7 mg per ounce
Sunflower or safflower oil — about 5.5 mg per tablespoon
Hazelnuts — about 4 mg per ounce
Peanut butter, avocado, spinach and broccoli — smaller amounts

Amounts are approximate and vary by product and preparation. U.S. Department of Agriculture. USDA ARS. 2024. Open Source ↗

8. What Body Systems Does Vitamin E Support?

Key Takeaway

Vitamin E supports cell membranes and antioxidant defense, the nervous system, the eyes, immune function, and skin — all about supporting normal structure and function.

Each of these is about supporting normal structure and function — not acting on any specific condition.

Cells and antioxidant defense. Supports protection of the fats in your cell membranes from oxidative damage. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗
Nervous system. Supports normal nerve and muscle function — which is why a long-term shortfall shows up as coordination and sensation problems. Schuelke. GeneReviews (NCBI Bookshelf NBK1241). 2023. Open Source ↗
Eyes. Present in the retina; supports the eye's antioxidant defenses. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗
Immune function. Supports normal immune-cell function, studied especially in older adults. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗
Skin. Supports skin's antioxidant defenses. (Applying it to scars is popular but isn't supported — see Section 9.) Baumann. Dermatologic Surgery. 1999. Open Source ↗

9. Frequently Asked Questions

Key Takeaway

Common questions about scars, dosing, natural vs. synthetic, heart health, timing, combining with fish oil, and the vaping-illness mix-up.

Does vitamin E help scars or skin if I rub it on?

Topical vitamin E is popular, but controlled studies have not shown it improves the look of scars — and it caused skin irritation in a notable share of people in one well-known study. Baumann. Dermatologic Surgery. 1999. Open Source ↗

How much vitamin E should I take?

The Daily Value is 15 mg, and the upper limit for adults from supplements is 1,000 mg per day in the US. Most people who eat a varied diet don't need a supplement at all. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗

Natural vs. synthetic vitamin E — does it matter?

Yes. The natural form (d-alpha) is about twice as potent per milligram as the synthetic form (dl-alpha), so the same milligram number delivers more. Traber. Basic Clin Pharmacol Toxicol. 2026. Open Source ↗

Is more vitamin E better for my heart?

No. Large studies found no heart benefit from vitamin E supplements, and high doses carry risks such as increased bleeding and a small rise in overall risk. Yusuf. New England Journal of Medicine. 2000. Open Source ↗Miller. Annals of Internal Medicine. 2005. Open Source ↗

How long until I notice something?

Blood levels rise within a few days, but most people won't “feel” a change. Vitamin E is preventive nutrition rather than a fast-acting remedy. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗

Can I take vitamin E with fish oil?

Usually fine at normal amounts — vitamin E even helps keep fish oil from going rancid — but high combined doses can add to bleeding risk. Owen. StatPearls (NCBI Bookshelf NBK564373). 2023. Open Source ↗

Is vitamin E linked to the vaping lung illness I heard about?

A form called vitamin E acetate, added to some illicit vaping products, caused a serious lung injury when inhaled. That has nothing to do with eating vitamin E or using it on your skin — the danger was specific to breathing it into the lungs. Blount. New England Journal of Medicine. 2019. Open Source ↗

10. How to Choose a Quality Supplement

Key Takeaway

Check the form (natural d-alpha vs. synthetic dl-alpha; mixed tocopherols), look for third-party verification like USP, and mind the units — no brands needed.

If you and your provider decide a supplement makes sense, here's what to look for — no specific brands, just what matters.

Check the form. “d-alpha-tocopherol” is natural; “dl-alpha” is synthetic; “mixed tocopherols” adds gamma-tocopherol. Traber. Basic Clin Pharmacol Toxicol. 2026. Open Source ↗
Look for third-party verification such as a USP seal, indicating the product was independently checked. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗
Mind the units. Labels now use milligrams; 15 mg equals about 22 IU as the natural form (d-alpha) or 33 IU as the synthetic form (dl-alpha). Traber. Basic Clin Pharmacol Toxicol. 2026. Open Source ↗
Sourcing, if you care about it. Most vitamin E is recovered from plant-oil processing (soybean, sunflower, palm), so sourcing varies. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗

11. Your Genes & Vitamin E

Key Takeaway

For most people, genetics don't change how to use vitamin E. One active research area — a common haptoglobin variation — is promising but not a reason to get tested.

For most people, genetics don't change how to use vitamin E, and there's no need to get genetic testing for it. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗

One area of active research stands out: a common inherited difference in a blood protein called haptoglobin. People with the “2-2” type appear to handle oxidative stress differently, and some studies suggest they respond to vitamin E differently than others. This is genuinely interesting science — but it's still research, not established medical guidance, and it isn't a reason to take high-dose vitamin E or order a gene test. Milman. Arterioscler Thromb Vasc Biol. 2008. Open Source ↗

12. Traditional Roots

Key Takeaway

Vitamin E has no traditional-medicine history — it's a 20th-century discovery, not a herb. Its “tradition” is scientific, starting with its 1922 discovery.

Honestly, vitamin E doesn't have a traditional-medicine history — and that's worth saying plainly. Unlike many herbs, it was never part of older systems such as traditional Chinese medicine or Ayurveda. The reason is simple: it wasn't discovered until the 20th century, and it isn't a plant remedy — it's a nutrient scientists isolated from food. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗

Its “tradition,” if it has one, is scientific. It was discovered in 1922 as a dietary factor animals needed for healthy reproduction — which is how it earned the chemical name “tocopherol,” from Greek words meaning “to carry offspring.”

13. The Story Behind the Science

Key Takeaway

From its 1922 discovery to the disappointing large prevention trials of the 1990s–2000s, vitamin E research has shifted to asking who specifically benefits.

1922 — discovery. Researchers identified a then-unknown fat-soluble dietary factor essential for reproduction in animals.
1936 — isolated and named. The active compound was isolated from wheat germ oil and named alpha-tocopherol.
Mid-1900s — the human picture. Scientists connected human shortfalls to fat-absorption problems and worked out the antioxidant role. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗
1990s–2000s — the big trials. Large prevention studies tested high-dose vitamin E against heart disease and cellular-health concern; many were disappointing and a few raised safety concerns at high doses. Yusuf. New England Journal of Medicine. 2000. Open Source ↗Miller. Annals of Internal Medicine. 2005. Open Source ↗
Today — a sharper question. Research has shifted from “does everyone benefit?” to “who specifically benefits?” — people under high oxidative stress, certain genetic subgroups, and specific liver situations.

14. Blood Tests That May Show Changes

Key Takeaway

The standard test is serum alpha-tocopherol, read alongside your blood fats. High-dose vitamin E can lengthen clotting tests — a real effect, not a lab error.

The standard test is a blood (serum) alpha-tocopherol level — a typical adult range is about 5.5 to 17 mg/L. It should be read alongside your blood fats (cholesterol and triglycerides), because vitamin E travels through the blood attached to those fats; a level that looks low or high can simply reflect your blood-fat level. Thurnham. Annals of Clinical Biochemistry. 1986. Open Source ↗

If you take high-dose vitamin E, it can lengthen clotting-test results (such as PT/INR) because of its mild blood-thinning effect. That's a real biological effect, not a lab error — worth mentioning to whoever orders the test. Booth. American Journal of Clinical Nutrition. 2004. Open Source ↗

Unlike vitamin C, vitamin E is not a common source of interference in routine lab chemistry. Owen. StatPearls (NCBI Bookshelf NBK564373). 2023. Open Source ↗

✓ Last Reviewed: June 2026

Vitamin E

Clinical Reference — Technical Data

Clinician-facing technical reference covering identification, mechanism, pharmacokinetics, organ-system effects, dose tiers, clinical evidence, pharmacogenomics, adverse effects, interactions, cautions, combinations, and lab monitoring.

CLINICAL SUMMARY

Vitamin E (alpha-Tocopherol; tocopherol/tocotrienol family, 8 vitamers)

Essential lipid-soluble, chain-breaking antioxidant of cell membranes; alpha-tocopherol is the physiologically retained vitamer, selected post-absorption by hepatic alpha-TTP and exported on VLDL.

Overall Evidence

MODERATE

What Has Been Studied

MODERATEBiopsy-confirmed liver-fat condition in non-blood-sugar adults (investigational) · 800 IU/d improved hepatic histology vs placebo in one Phase-III RCT — a supervised clinical-trial finding, not a structure/function use or an FDA-recognized indication (see §6)
MODERATEMacular/eye-health support (age-related) · antioxidant + zinc combination slowed progression; vitamin E monotherapy null (see §6)
LIMITEDHaptoglobin 2-2 genotype with type 2 blood-sugar conditions (investigational) · CV-event reduction in subgroup analyses; an investigational pharmacogenomic signal, not guideline-endorsed and not an indication (see §6, §8)
INSUFFICIENTGeneral-population cardiovascular / cellular-health support · large RCTs null (HOPE, WHS, HPS); USPSTF D recommendation (see §6)

Standard Dose Range

Dietary: RDA 15 mg/d adults (~22.4 IU RRR / 33.3 IU all-rac); UL 1000 mg/d US, 300 mg/d EFSA (see §5)
Functional: 100-400 IU/d in immune/oxidative-endpoint studies (~200 mg optimal in elderly); risk rises >=400 IU/d (see §5)
High-Dose Tier: 800 IU/d (liver-fat condition, AMD trials); AVED 800-1500 mg/d lifelong, specialist (see §5)

Key Safety Flags

🟠 CAUTION Bleeding: antiplatelet + vitamin-K antagonism at high dose; additive with anticoagulants/antiplatelets (>=300 mg/d)
🟠 CAUTION >=400 IU/d associated with increased all-cause mortality (dose-response meta-analysis)
🟠 CAUTION Hemorrhagic cerebrovascular event +22% at high dose; prostate-health signal in SELECT
🟠 CAUTION Pregnancy/lactation P-2 / T-M: dietary compatible, high-dose not recommended
🔴 AVOID IV vitamin E in preterm/VLBW infants (historical E-Ferol fatal events)

Monitoring Quick-Ref

Serum alpha-tocopherol (lipid-adjusted): ~5.5-17 mg/L; interpret via alpha-toc:total-lipid or :cholesterol ratio (see §12)
PT/INR: when anticoagulated and on high-dose vitamin E (functional vitamin-K antagonism) (see §10d)

⚠️ Lab Interference

alpha-Tocopherol is NOT a documented analytical interferent in routine clinical chemistry or immunoassay panels (cardiac, thyroid, reproductive/hormone, stress, oncology-marker, inflammatory) — distinct from ascorbate. The single real laboratory effect is functional, not analytical: high-dose (>=1000 IU/d) alpha-tocopherol antagonizes vitamin K, prolonging PT/INR and raising PIVKA-II; high dose also lowers serum gamma-tocopherol (see §10c).

Clinical bottom line: Vitamin E is an essential antioxidant with specific findings in supervised clinical research (biopsy-proven non-blood-sugar-condition liver-fat condition; AMD antioxidant-combination; the Hp2-2 blood-sugar-condition subgroup) — none of which is a structure/function use or an FDA-recognized indication for the supplement — and no demonstrated general chronic-disease-prevention benefit and an established high-dose harm signal (all-cause mortality, bleeding-type cerebrovascular events, bleeding, SELECT prostate signal). Reserve high-dose use for defined indications under supervision; dietary intake is safe and adequate for most patients.

1. Chemical Identity & Forms

Key Takeaway

Eight lipid-soluble vitamers; alpha-tocopherol is the retained form. RRR (natural, 1.49 IU/mg) vs all-rac (synthetic, 2.22 IU/mg); GRAS, esters and water-miscible derivatives available.

“Vitamin E” denotes eight vitamers: alpha-, beta-, gamma-, delta-tocopherol (saturated tail) and the four corresponding tocotrienols (unsaturated tail). alpha-Tocopherol is the form maintained in human plasma and tissue. Traber. Basic Clin Pharmacol Toxicol. 2026. Open Source ↗

alpha-Tocopherol — RRR (natural, single stereoisomer; CAS 59-02-9) vs all-rac (synthetic 8-isomer mixture; CAS 10191-41-0); C₂₉H₅₀O₂, MW 430.71, PubChem CID 14985.
Biopotency: 1 mg RRR = 1.49 IU, 1 mg all-rac = 2.22 IU (IU label-conversion factors); only 2R stereoisomers are biologically retained, so 1 mg alpha-tocopherol = 1 mg RRR = 2 mg all-rac (natural ~2x the biological potency of synthetic per mg); DV 15 mg.
Forms: free alcohol; esters (acetate, succinate, palmitate) for oxidative stability (require luminal hydrolysis); water-miscible TPGS / tocofersolan for malabsorption.

Regulatory: GRAS under 21 CFR 184.1890; food additive E306-E309. U.S. Code of Federal Regulations. U.S. eCFR. 2024. Open Source ↗ NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗

2. Mechanism of Action

Key Takeaway

Lipid-phase chain-breaking peroxyl-radical scavenger (tocopheroxyl recycled by ascorbate); non-antioxidant PKC/PXR-CYP3A roles; cooperates with GPX4 to suppress ferroptosis; a hydroquinone metabolite is a potent 15-LOX regulator.

Antioxidant (primary). alpha-Tocopherol scavenges lipid peroxyl radicals (LOO•), interrupting PUFA peroxidation in membranes and lipoproteins; the tocopheroxyl radical is reduced back to alpha-tocopherol by ascorbate. Traber. Basic Clin Pharmacol Toxicol. 2026. Open Source ↗

Non-antioxidant / signaling. Modulates protein kinase C and gene expression independent of radical scavenging, and induces CYP3A via the pregnane-X receptor (PXR) — the basis of several drug interactions. Traber. Basic Clin Pharmacol Toxicol. 2026. Open Source ↗

Ferroptosis suppression (emerging). alpha-Tocopherol cooperates with glutathione peroxidase 4 (GPX4) to prevent iron-dependent lipid-peroxidation cell death; hepatocyte GPX4 deletion is lethal and rescued by dietary vitamin E. Carlson. Redox Biology. 2016. Open Source ↗ An alpha-tocopherol hydroquinone metabolite is a far more potent ferroptosis inhibitor than alpha-tocopherol itself, acting via 15-lipoxygenase. Hinman. PLoS ONE. 2018. Open Source ↗

Vitamer-distinct biology. gamma-Tocopherol traps reactive nitrogen species/peroxynitrite (forming 5-nitro-gamma-tocopherol), complementing alpha-tocopherol. Christen. PNAS. 1997. Open Source ↗

3. Pharmacokinetics (ADME)

Key Takeaway

Bile/fat-dependent absorption (no vitamer-specific transporter); hepatic alpha-TTP selects RRR for VLDL export; CYP4F2/3A omega-hydroxylation to CEHC; plasma t1/2 ~48-73 h, adipose ~184 d, body pool ~11 g.

Absorption: requires bile, pancreatic esterase, and dietary fat; nutritional bioavailability ~50-80%. No vitamer-specific transporter — all eight are absorbed comparably; discrimination is post-absorptive. Traber. Basic Clin Pharmacol Toxicol. 2026. Open Source ↗
Distribution: hepatic alpha-TTP (~32 kDa) selectively binds RRR-alpha-tocopherol and loads it onto nascent VLDL, explaining plasma predominance; TTPA loss-of-function causes AVED. Meier. Journal of Molecular Biology. 2003. Open Source ↗
Metabolism: excess and non-alpha vitamers undergo CYP4F2/CYP3A omega-hydroxylation then beta-oxidation to carboxyethyl-hydroxychroman (CEHC) metabolites; urinary alpha-CEHC reflects sufficiency. Traber. Basic Clin Pharmacol Toxicol. 2026. Open Source ↗
Kinetics: plasma t1/2 ~48-73 h; steady state by day 4-5; adipose pool t1/2 ~184 d; body store ~11 g; plasma normalizes ~12-20 d after discontinuation. Traber. Basic Clin Pharmacol Toxicol. 2026. Open Source ↗
Genetic PK lesions: AVED (TTPA) and abetalipoproteinemia (MTTP). Schuelke. GeneReviews (NCBI Bookshelf NBK1241). 2023. Open Source ↗

4. Organ System Effects

Key Takeaway

Neurologic (spinocerebellar/posterior-column integrity), ophthalmic (retinal antioxidant), immune (T-cell, lower PGE2), hepatic (anti-ferroptotic), and hematologic/vascular (membrane stability, LDL-oxidation, antiplatelet).

Neurologic: maintains spinocerebellar and posterior-column integrity; chronic deficiency causes spinocerebellar ataxia, peripheral nerve changes, areflexia. Schuelke. GeneReviews (NCBI Bookshelf NBK1241). 2023. Open Source ↗
Ophthalmic: retinal antioxidant; high-dose vitamin E was associated with faster retinal-function decline in retinitis pigmentosa. Berson. Archives of Ophthalmology. 1993. Open Source ↗
Immune: supports T-cell function and lowers PGE2; supplementation studied for delayed-type hypersensitivity in the elderly. Meydani. JAMA. 1997. Open Source ↗
Hepatic: anti-ferroptotic protection of hepatocytes — the mechanistic basis for the liver-health histology signal. Carlson. Redox Biology. 2016. Open Source ↗
Hematologic/vascular: RBC membrane stabilization; inhibits LDL oxidation; high dose produces an antiplatelet/antithrombotic effect. Owen. StatPearls (NCBI Bookshelf NBK564373). 2023. Open Source ↗

5. Dose Tiers

Key Takeaway

Dietary: RDA 15 mg/d, UL 1000 mg/d US (300 mg/d EFSA). Functional 100-400 IU/d. High-dose 800 IU/d (liver-fat condition, AMD) and AVED 800-1500 mg/d lifelong; risk signal >=400 IU/d.

Dietary tier

US (IOM/NASEM): EAR 12 mg/d, RDA 15 mg/d adults, UL 1000 mg/d. Institute of Medicine. National Academies Press (NCBI Bookshelf NBK225461). 2000. Open Source ↗ EFSA: AI 13 mg/d (men) / 11 mg/d (women); UL 300 mg/d. EFSA NDA Panel. EFSA Journal. 2015. Open Source ↗EFSA NDA Panel. EFSA Journal. 2024. Open Source ↗

Functional tier

100-400 IU/d studied for oxidative-stress and immune endpoints (~200 mg/d optimal for elderly immune markers). Meydani. JAMA. 1997. Open Source ↗ Time-to-effect: plasma steady state day 4-5; in-vivo F2-isoprostane reduction by ~2 weeks only in high-oxidative-stress states, explaining null healthy-population trials. Davi. PNAS / Circulation (PMC134477). 1999. Open Source ↗

High-dose tier — risk-profile note

Doses studied: 800 IU/d (PIVENS liver-fat condition; AREDS AMD-combination). Sanyal. New England Journal of Medicine. 2010. Open Source ↗ AVED 800-1500 mg/d (40 mg/kg/d in children) lifelong; cystic fibrosis 100-400 IU/d. Schuelke. GeneReviews (NCBI Bookshelf NBK1241). 2023. Open Source ↗
Investigational status: not FDA-approved as a drug; tocofersolan (Vedrop) is EMA-approved for pediatric cholestatic vitamin-E deficiency. European Medicines Agency. EMA. 2009. Open Source ↗
Supervision: >=400 IU/d carries the mortality/bleeding signal — specialist supervision advised. Miller. Annals of Internal Medicine. 2005. Open Source ↗

6. Clinical Evidence

Key Takeaway

Three States: supportive (PIVENS, AREDS, ICARE), null (HOPE/HOPE-TOO, WHS, HPS), and adverse (Miller mortality, SELECT prostate, Schurks bleeding-type cerebrovascular events, Cochrane, USPSTF D). Benefit concentrates in high-oxidative-stress states.

Three States preserved: supportive, null, and adverse findings are all reported in evidence-description language. The overall pattern is benefit confined to specific populations while general-prevention trials are null-to-adverse.

Supportive

PIVENS evaluated 800 IU/d RRR-alpha-tocopherol x 96 wk in biopsy-confirmed liver-fat condition in non-blood-sugar adults and reported liver-fat-condition resolution in 36% vs 21% placebo. Sanyal. New England Journal of Medicine. 2010. Open Source ↗
AREDS Report 8 reported progression to advanced AMD was about 25% slower with an antioxidant + zinc formulation; vitamin E monotherapy trials were null. Age-Related Eye Disease Study Research Group. Archives of Ophthalmology. 2001. Open Source ↗
ICARE reported a reduced composite of cerebrovascular event/MI/CV death (2.2% vs 4.7%) with 400 IU/d in type 2 blood-sugar conditions + haptoglobin 2-2. Milman. Arterioscler Thromb Vasc Biol. 2008. Open Source ↗
ATBC reported lower rates of an adverse prostate-health outcome as a secondary outcome in male smokers — not replicated by SELECT. ATBC Study Group. New England Journal of Medicine. 1994. Open Source ↗

Null

HOPE reported no reduction in cardiovascular events with 400 IU/d in high-risk adults; HOPE-TOO follow-up reported increased heart-health hospitalization. Yusuf. New England Journal of Medicine. 2000. Open Source ↗Lonn. JAMA. 2005. Open Source ↗
The Women's Health Study (600 IU alternate-day) reported no cardiovascular or cellular-health benefit. Lee. JAMA. 2005. Open Source ↗
The Heart Protection Study antioxidant arm in 20,536 adults reported no benefit. Heart Protection Study Collaborative Group. The Lancet. 2002. Open Source ↗

Adverse

Miller's dose-response meta-analysis reported increased all-cause mortality at >=400 IU/d. Miller. Annals of Internal Medicine. 2005. Open Source ↗
SELECT reported higher rates of an adverse prostate-health outcome (HR 1.17) in healthy men. Klein. JAMA. 2011. Open Source ↗
Schurks reported bleeding-type cerebrovascular events +22% and clot-type cerebrovascular events -10% at high dose. Schürks. BMJ. 2010. Open Source ↗
A Cochrane review reported increased mortality with antioxidant supplements; USPSTF issued a D recommendation against vitamin E for cardiovascular/cellular-health support. Bjelakovic. Cochrane Database of Systematic Reviews. 2012. Open Source ↗US Preventive Services Task Force. JAMA. 2022. Open Source ↗

Responder synthesis

Benefit concentrates in high-oxidative-stress states — SPACE (hemodialysis + CVD) and CHAOS (angiographic coronary findings) — and in the Hp2-2 genotype. Boaz. The Lancet (PMC7737178 synthesis). 2000. Open Source ↗

7. Pharmacogenomics & Genetics

Key Takeaway

Haptoglobin Hp2-2 is the principal signal (~34% CV-event reduction in Hp2-2 individuals with blood-sugar conditions; discontinuation -> 4.5x MI), not guideline. Status SNPs CYP4F2/SCARB1/APOA5 (~1.7% variance). TTPA -> AVED.

Haptoglobin (Hp) genotype — principal signal. In type 2 blood-sugar conditions, pooled Hp-stratified analyses reported fewer cardiovascular events with vitamin E in Hp2-2 individuals, a possible signal in non-Hp2-2, and a 4.5x rise in MI after discontinuation in Hp2-2 individuals with blood-sugar conditions. This is a pharmacogenomic research signal, not a guideline recommendation, and does not justify routine Hp genotyping. Milman. Arterioscler Thromb Vasc Biol. 2008. Open Source ↗Blum. Pharmacogenomics. 2010. Open Source ↗

Status variants. A GWAS identified CYP4F2 (rs2108622), SCARB1 (rs11057830), and the APOA5 region (rs964184) associated with circulating alpha-tocopherol, explaining ~1.7% of variance — insufficient to change dosing. Major. Human Molecular Genetics. 2011. Open Source ↗

Monogenic. TTPA loss-of-function causes ataxia with vitamin E deficiency (AVED); MTTP causes abetalipoproteinemia. Schuelke. GeneReviews (NCBI Bookshelf NBK1241). 2023. Open Source ↗

8. Adverse Effects

Key Takeaway

Well tolerated at dietary intake; the adverse profile is a high-dose phenomenon. Bleeding is principal; >=400 IU/d mortality signal; E-Ferol (IV, preterm) historical catastrophe; EVALI is a distinct inhalational toxicity.

Three States preserved (common / serious / population-specific). Vitamin E is well tolerated at dietary intake; the profile below is essentially a high-dose-supplement profile.

Common (high-dose): GI upset, nausea, diarrhea, headache, fatigue, occasional emotional lability. Owen. StatPearls (NCBI Bookshelf NBK564373). 2023. Open Source ↗
Serious — bleeding (principal): antiplatelet effect plus functional vitamin-K antagonism; bleeding-type cerebrovascular signal at high dose. Booth. American Journal of Clinical Nutrition. 2004. Open Source ↗Schürks. BMJ. 2010. Open Source ↗
Serious — mortality signal: >=400 IU/d associated with increased all-cause mortality. Miller. Annals of Internal Medicine. 2005. Open Source ↗
Population-specific — E-Ferol (1984): an injected vitamin E product in preterm/VLBW infants caused ascites, hepatomegaly, cholestasis, thrombocytopenia, and deaths (polysorbate vehicle + rapid IV implicated); withdrawn 1984. Centers for Disease Control. MMWR. 1984. Open Source ↗Bove. JAMA. 1985. Open Source ↗Arrowsmith. Pediatrics. 1989. Open Source ↗
Inhalational (distinct route) — EVALI: vitamin E acetate in illicit THC vaping products was detected in 94% of EVALI bronchoalveolar-lavage samples (vs 0 controls); pyrolysis yields ketene. Mechanistically and clinically distinct from oral or topical vitamin E. Blount. New England Journal of Medicine. 2019. Open Source ↗

9. Drug Interactions

Key Takeaway

Nutritional doses: no important interactions. High dose (>=300 mg/d): additive bleeding with anticoagulants/antiplatelets (major); contested statin-niacin and chemo/radiation effects; CYP/OATP with cyclosporine/tamoxifen.

Warfarin, heparin, DOACs (Major): additive anticoagulation + functional vitamin-K antagonism; monitor PT/INR; >=300 mg/d. Booth. American Journal of Clinical Nutrition. 2004. Open Source ↗Podszun. Nutrition Research Reviews. 2014. Open Source ↗
Aspirin, clopidogrel (Major): additive antiplatelet/bleeding effect at high dose. Owen. StatPearls (NCBI Bookshelf NBK564373). 2023. Open Source ↗
Statin + niacin (Moderate/contested): an antioxidant cocktail including 800 IU vitamin E blunted the HDL2/apoA1 rise in HATS. Brown. New England Journal of Medicine. 2001. Open Source ↗
Chemotherapy / radiotherapy (Contested): antioxidants may reduce treatment toxicity but could protect rapidly-dividing cells; evidence inconsistent — avoid unsupervised high dose. Lawenda. JNCI. 2008. Open Source ↗
Cyclosporine A; tamoxifen (Moderate): possible OATP/CYP-mediated alteration at >=300 mg/d. Podszun. Nutrition Research Reviews. 2014. Open Source ↗
Bile-acid sequestrants, orlistat: reduce vitamin E absorption (deplete vitamin E, not the reverse). NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗

Nutritional-dose vitamin E shows no clinically important interactions; the interaction profile is a high-dose (>=300 mg/d) phenomenon. Podszun. Nutrition Research Reviews. 2014. Open Source ↗

10. Cautions and Considerations

Key Takeaway

Strong: IV vitamin E in preterm/VLBW; high-dose in retinitis pigmentosa. Relative: anticoagulation, pre-surgery, a prior bleeding-type cerebrovascular event, active cellular-health conditions on chemo/radiotherapy, smokers + beta-carotene. Block F (10a-10d) follows.

Strong: injected vitamin E in preterm/VLBW infants (historical fatal events) Centers for Disease Control. MMWR. 1984. Open Source ↗Arrowsmith. Pediatrics. 1989. Open Source ↗; high-dose vitamin E in retinitis pigmentosa (400 IU/d associated with faster retinal-function decline). Berson. Archives of Ophthalmology. 1993. Open Source ↗ Relative: therapeutic anticoagulation/antiplatelet therapy, the immediate pre-operative period, a prior bleeding-type cerebrovascular event, an active cellular-health condition on chemo/radiotherapy, and smokers combined with beta-carotene. Dietary intake is not restricted in any of these. Pham. Pharmacotherapy / review. 2010. Open Source ↗

10a. Patient Population Red Flags

Renal: 🟡 ADJUST — hemodialysis + CVD a possible responder sub-population (SPACE); high-dose bleeding caution. Boaz. The Lancet (PMC7737178 synthesis). 2000. Open Source ↗
Hepatic: 🟡 ADJUST — cholestasis/fat-malabsorption impairs status (water-miscible forms); not a high-dose caution. European Medicines Agency. EMA. 2009. Open Source ↗
Pregnancy: 🟡 P-2 CAUTION — dietary/RDA compatible; high-dose not recommended; consult OB/MFM above maintenance. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗
Lactation: 🟡 T-M — secreted into milk, intake-dependent; RDA compatible. NIH Office of Dietary Supplements. NIH ODS. 2026. Open Source ↗
Pediatric: 🔴 IV / 🟢 dietary — IV in preterm/VLBW not advised (E-Ferol); dietary/age-RDA standard. Arrowsmith. Pediatrics. 1989. Open Source ↗
Geriatric >=65: 🟡 ADJUST — moderate-dose immune benefit; high-dose mortality/bleeding signal. Meydani. JAMA. 1997. Open Source ↗Miller. Annals of Internal Medicine. 2005. Open Source ↗
Polypharmacy: 🟠 CAUTION — anticoagulant/antiplatelet + CYP3A/OATP at >=300 mg/d. Podszun. Nutrition Research Reviews. 2014. Open Source ↗
Peri-operative: 🟠 CAUTION — discontinue high-dose ~2 weeks pre-procedure. Pham. Pharmacotherapy / review. 2010. Open Source ↗
Athlete (WADA): 🟢 STANDARD — not WADA-prohibited; high-dose vit C+E may blunt training adaptation.

10b. Drug-Nutrient Depletion Table

Drug / agent	Direction	Mechanism	Management
Orlistat	↓ vitamin E status	Lipase inhibition reduces fat-soluble vitamin absorption	Separate dosing; monitor status with chronic use
Bile-acid sequestrants (cholestyramine, colestipol)	↓ vitamin E status	Bind bile acids required for micellar absorption	Separate by several hours; monitor status
Vitamin K (functional)	↓ vitamin K activity	High-dose alpha-tocopherol antagonizes vitamin K — the only nutrient-level effect; vitamin E does not deplete other micronutrients	Monitor PT/INR when anticoagulated

Vitamin E status is reduced by orlistat and bile-acid sequestrants; conversely, vitamin E does not clinically deplete other micronutrients (its only nutrient-level antagonism is functional vitamin-K antagonism at high dose). Booth. American Journal of Clinical Nutrition. 2004. Open Source ↗

10c. Lab Interference Panel

Category	Tests	Effect	Consequence
Cardiac / thyroid / hormone / oncology-marker / inflammatory	Troponin, NT-proBNP, TSH, FT4, hCG, FSH/LH, estradiol, testosterone, cortisol, CA-125, CRP	No documented analytical interference	Interpret normally — distinct from ascorbate
Coagulation (functional)	PT/INR, PIVKA-II	Prolonged PT/INR, raised PIVKA-II at >=1000 IU/d	Functional vitamin-K antagonism, not analytical; monitor if anticoagulated
Vitamin E status	Serum gamma-tocopherol	Lowered by high-dose alpha-tocopherol	Physiologic displacement, not assay error

The single real laboratory effect is functional (coagulation), not analytical; alpha-tocopherol is not a documented interferent across routine chemistry or immunoassay panels. Owen. StatPearls (NCBI Bookshelf NBK564373). 2023. Open Source ↗Booth. American Journal of Clinical Nutrition. 2004. Open Source ↗

10d. Monitoring Protocol Template (with Discontinuation)

Baseline/periodic serum alpha-tocopherol (lipid-adjusted) for chronic high-dose use or malabsorption; PT/INR when anticoagulated and on high-dose vitamin E. Thurnham. Annals of Clinical Biochemistry. 1986. Open Source ↗
AVED: plasma alpha-tocopherol every ~6 months targeting high-normal; lifelong; presymptomatic treatment prevents onset. Schuelke. GeneReviews (NCBI Bookshelf NBK1241). 2023. Open Source ↗
Discontinuation — general: no taper or rebound; plasma normalizes ~12-20 days. Exceptions: AVED must NOT be stopped (neurologic progression); in Hp2-2 individuals with blood-sugar conditions one trial reported a 4.5x MI rise after discontinuation; hold high-dose ~2 weeks peri-operatively.

11. Combinations & Synergy

Key Takeaway

Vitamin C regenerates tocopheroxyl; selenium/GPx complementary (ferroptosis); mixed tocopherols preserve gamma. Negative stacking: high-dose alpha displaces other vitamers; antioxidant blunting of statin-niacin.

Vitamin C: regenerates the tocopheroxyl radical — co-antioxidant; constrains the pro-oxidant mode of high-dose alpha-tocopherol. Traber. Basic Clin Pharmacol Toxicol. 2026. Open Source ↗
Selenium / GPx: complementary antioxidant defense (GPX4 + vitamin E jointly suppress ferroptosis). Carlson. Redox Biology. 2016. Open Source ↗
Mixed tocopherols: preserve gamma-tocopherol (RNS trapping) that high-dose alpha-tocopherol displaces. Christen. PNAS. 1997. Open Source ↗

Negative stacking: high-dose alpha-tocopherol displaces other vitamers (a candidate mechanism for the mortality signal) Gee. Genes & Nutrition. 2010. Open Source ↗; antioxidant blunting of the statin-niacin HDL response. Brown. New England Journal of Medicine. 2001. Open Source ↗

12. Lab Monitoring + Repletion

Key Takeaway

Serum alpha-tocopherol as a lipid ratio (alpha-toc:total lipid <0.8 mg/g = deficiency; alpha-toc:cholesterol preferred). Repletion: ordinary 60-75 IU, CF 100-400 IU, AVED 800-1500 mg/d. Oxidative-marker response ~2 wk (high-oxidative-stress only).

Status assessment: serum alpha-tocopherol interpreted as a lipid ratio — alpha-toc:total lipid <0.8 mg/g indicates deficiency; alpha-toc:cholesterol is preferred. Functional adjuncts: erythrocyte H2O2-hemolysis test and urinary alpha-CEHC. Reference range ~5.5-17 mg/L, lipid-adjusted. Thurnham. Annals of Clinical Biochemistry. 1986. Open Source ↗Owen. StatPearls (NCBI Bookshelf NBK564373). 2023. Open Source ↗

Repletion: ordinary deficiency 60-75 IU/d; cystic fibrosis 100-400 IU/d; AVED 800-1500 mg/d (40 mg/kg/d in children). Schuelke. GeneReviews (NCBI Bookshelf NBK1241). 2023. Open Source ↗ Time-to-effect: plasma steady state day 4-5; oxidative-marker response by ~2 weeks in high-oxidative-stress states only. Davi. PNAS / Circulation (PMC134477). 1999. Open Source ↗

13. Traditional Medicine

Key Takeaway

20th-century isolate with no traditional-medicine pedigree (discovered 1922, isolated 1936, synthesized 1938). Popular topical scar use is not supported by controlled evidence.

Vitamin E is a 20th-century isolate with no traditional-medicine pedigree — no documented use in traditional Chinese medicine, Ayurveda, or ethnobotanical systems (it is a nutrient isolated from food, not a botanical). Discovered in 1922 (Evans & Bishop), isolated from wheat-germ oil and named alpha-tocopherol in 1936, first synthesized by Karrer in 1938. Wolf. History of nutrition (review). 1977. Open Source ↗

The popular topical use on scars is not supported by controlled evidence (one RCT reported no cosmetic benefit and ~33% contact skin irritation). Baumann. Dermatologic Surgery. 1999. Open Source ↗

14. Quality Control

Key Takeaway

Disclose natural (d-/RRR) vs synthetic (dl-/all-rac); esters for stability; water-miscible for malabsorption; USP verification; sourcing from deodorizer distillate (soy/sunflower/palm); E306-309 food-additive identity.

Form/source disclosure: natural (d-/RRR) vs synthetic (dl-/all-rac) affects biopotency and stereoisomer profile; esters (acetate, succinate) improve shelf stability; water-miscible TPGS/tocofersolan for malabsorption. Traber. Basic Clin Pharmacol Toxicol. 2026. Open Source ↗
Verification: USP reference standards and third-party verification confirm identity/potency; mixed-tocopherol products should declare gamma-tocopherol content.
Sourcing & sustainability: most natural tocopherol is recovered from edible-oil deodorizer distillate (soybean, sunflower, palm) — a byproduct-valorization positive; palm/soy sourcing raises land-use concerns, and quantitative cradle-to-gate LCA data are a genuine literature gap.
Food-additive identity: E306 (tocopherol-rich extract), E307 (alpha-), E308 (gamma-), E309 (delta-tocopherol); GRAS 21 CFR 184.1890. U.S. Code of Federal Regulations. U.S. eCFR. 2024. Open Source ↗EFSA ANS Panel. EFSA Journal. 2015. Open Source ↗

✓ Last Reviewed: June 2026

Clinical decisions remain the responsibility of the prescribing clinician.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Your cart is empty

Vitamin E: Benefits, Uses, Forms, and Safety

1. What Is Vitamin E?

2. Signs You May Be Running Low

3. Who Should Be Careful or Avoid

4. How to Get the Best Results

5. Side Effects to Know About

6. What Research Suggests

7. Top Food Sources

8. What Body Systems Does Vitamin E Support?

9. Frequently Asked Questions

Does vitamin E help scars or skin if I rub it on?

How much vitamin E should I take?

Natural vs. synthetic vitamin E — does it matter?

Is more vitamin E better for my heart?

How long until I notice something?

Can I take vitamin E with fish oil?

Is vitamin E linked to the vaping lung illness I heard about?

10. How to Choose a Quality Supplement

11. Your Genes & Vitamin E

12. Traditional Roots

13. The Story Behind the Science

14. Blood Tests That May Show Changes